OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 5.60
-0.30 (-5.08%)
At close: Mar 27, 2026
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 78.67 million as of March 27, 2026. Its market cap has increased by 11.75% in one year.
Market Cap
78.67M
Enterprise Value
82.46M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.60
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 78.67M, a decrease of -11.63%. That is a compound annual growth rate of -2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 78.67M | -7.98% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 114.67M |
| Alligator Bioscience AB | 106.53M |
| Biovica International AB | 105.09M |
| Annexin Pharmaceuticals AB | 98.12M |
| Scandinavian ChemoTech AB | 96.73M |
| Alzinova AB | 91.12M |
| Biosergen AB | 85.01M |
| Magle Chemoswed Holding AB | 81.77M |